Medical/Pharmaceuticals
Yiling Pharmaceutical Lianhua Qingwen capsules are widely used in China against the epidemic
SHIJIAZHUANG, China, April 13, 2020 /PRNewswire/ -- Wu Xiangjun, general manager of Yiling Pharmaceutical co., LTD., announced thatLianhua Qingwen capsules (granules) have been recommended by the National Health Commission and the State Administration of Traditional Medicine of China. The ministr...
2020-04-13 21:55
2010
Seegene Receives Health Canada Approval for its COVID-19 Assay
SEOUL, South Korea, April 13, 2020 /PRNewswire/ -- Seegene, Inc. announced that Health Canada (HC) authorized an interim order which allows the import and sale inCanada of Seegene's Allplex™ 2019-nCoV Assay, a Real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COVI...
2020-04-13 21:00
2352
Gracell to Present the First-in-human, Universal TruUCAR™ GC027 Therapy for Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia at the AACR Annual Meeting
SUZHOU, China and SHANGHAI, April 13, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell and gene therapy company, is pleased to announce that their first-in-human phase I data of UniversalTruUCAR™ GC027 in relapsed or refractory (R/R) T-cell acute l...
2020-04-13 21:00
1313
EmeTerm, by WAT Medical, an easy solution for Cyber Sickness
VANCOUVER, April 13, 2020 /PRNewswire/ -- WAT Medical Enterprise Ltd. conducted an investigation on solutions to cyber sickness (a form of nausea-induced vomiting). WAT Medical team has been studying has achieved positive results with the use of EmeTerm. Based on a large number of experimental te...
2020-04-13 21:00
1427
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions
SHANGHAI and MELBOURNE, Australia, April 13, 2020 /PRNewswire/ -- Antengene Corporation today announced the appointment of Mr. Thomas Karalis as Head of Asia Pacific Regions. In this position, Tom will be responsible for the commercialization of Antengene products inAustralia, New Zealand, S. Kor...
2020-04-13 20:00
3387
Ascletis Receives IND Approval for its HIV Drug ASC09F
HANGZHOU and SHAOXING, China, April 13, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that it received IND approval from National Medical Products Administration (NMPA) for its human immunodeficiency virus (HIV) protease inhibitor ASC09F (ASC09/Ritonavir Fixed-Dose C...
2020-04-13 20:00
3640
Cyient Receives ISO 13485 Quality Certification for ASIC Design and Supply
The new certification is in addition to the ISO 13485 certifications the company has had for engineering since 2009 and manufacturing since 2007 and is a testament to its expertise in developing advanced ICs for the MedTech market. HYDERABAD, India, April 13, 2020 /PRNewswire/ -- Cyient, a global...
2020-04-13 17:23
2187
AGC to Expand Its Spanish Synthetic Pharmaceutical Production Base for Capacity Increase and Establishment of New R&D Facility
TOKYO, April 10, 2020 /PRNewswire/ -- AGC Inc. (AGC), a world-leading manufacturer of glass, chemicals and high-tech materials, has announced its decision to expand facilities at its synthetic pharmaceutical (*1) CDMO (*2) business subsidiary, AGC Pharma Chemicals Europe S. L. U., headquartered i...
2020-04-10 14:00
2279
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment
SONGDO, South Korea and SAN FRANCISCO, April 9, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced a manufacturing agreement under which Samsung Biologics will perform large scale manufacturing services for Vir's SARS-CoV-2 monoclonal anti...
2020-04-10 11:39
2726
JNCCN: Improving COVID-19 Safety for Cancer Patients and Healthcare Providers
PLYMOUTH MEETING, Pennsylvania, April 9, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers--is continuing to share new resources for optimal cancer management amid new and changing challenges related to the Coronavirus Disease 2019 (COVI...
2020-04-09 20:35
1791
Seneca Biopharma Announces Results of Meeting with FDA Regarding the Design of Phase 3 Trial for NSI-566 in ALS
GERMANTOWN, Maryland, April 9, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a clinical-stage biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced that the company held a Type C meeting with the Office of Tissues a...
2020-04-09 20:00
3457
Merck and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO(R) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Not intended for US-, Canada- and UK-based media - Breakthrough Therapy Designation and Submission based on positive Phase III JAVELIN Bladder 100 study results - Supplemental Biologics License Application being reviewed under FDA Real-Time Oncology Review (RTOR) pilot program - JAVELIN B...
2020-04-09 18:00
5086
World-First Trial to Test Benefit of Intravenous Zinc in COVID-19 Fight
SYDNEY, April 9, 2020 /PRNewswire/ -- A world-first trial will see researchers from Austin Health and theUniversity of Melbourne use intravenous zinc to fight the symptoms of coronavirus (COVID-19). The trial will be led by Austin Health's Dr Joseph Ischia and Dr Oneel Patel from the Department ...
2020-04-09 15:57
1416
EHR Investments Increase as Governments and Healthcare Authorities Focus on Interoperability
Europe will see more partnerships for integrated care from the evolution of electronic health records, finds Frost & Sullivan LONDON, April 9, 2020 /PRNewswire/ -- The electronic medical record (EMR) market is likely to register impressive growth acrossEurope as it evolves into a morecomprehensi...
2020-04-09 15:50
2216
Bridge Biotherapeutics Discloses Interim Results from the First Cohort of Phase 2a Study of BBT-401, an Experimental Drug for Ulcerative Colitis
* The Interim data showed that 3 out of 9 evaluable patients on BBT-401 responded with more than 30% reduction in Total Mayo Score or 25% reduction in Partial Mayo Score * Safety and tolerability profiles remain consistent with results from Phase I trial in healthy volunteers SEONGNAM, South ...
2020-04-09 15:14
1450
Qiming Venture Partners Raises $1.1 Billion Fund VII
SHANGHAI, BEIJING, HONG KONG and SHENZHEN, China, April 9, 2020 /PRNewswire/ -- Qiming Venture Partners today announced the closing of Qiming Venture Partners Fund VII, a new$1.1B fund focused on early stage Healthcare and TMT investments. Qiming is honored to have continued strong support from i...
2020-04-09 09:18
4160
United Imaging Announces Rapid CT Deployment to Help Expand Capacity at Maimonides Medical Center
HOUSTON, April 8, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced that it has installed a transportable CT scanner at the request of Maimonides Medical Center, the largest hospital inBrooklyn, New York, on the front lines of t...
2020-04-08 20:00
1265
Samsung Biologics named Champion in 2020 CMO Leadership Awards
SONGDO, South Korea, April 8, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced that it has been awarded the 2020 CMO Leadership Awards for its excellence in the Capabilities, Compatibility, Quality, Reliability, and Service categories across Big Pharma and Overall (combined Big and Sm...
2020-04-08 20:00
1327
China-based Asclepius Metidec helps solve ventilator shortage with its innovative device
SHANGHAI, April 8, 2020 /PRNewswire/ -- An innovative technology-powered medical device developed by Chinese medical equipment provider Asclepius Metidec has been successfully used in the treatment of patients with confirmed COVID-19. The hydrogen oxygen nebulizer, as a result of nine years of r...
2020-04-08 17:35
1490
Aetna International Announces Waiver for Cost-sharing, Co-pay and Deductibles for COVID-19-related Inpatient Treatment
SINGAPORE, April 8, 2020 /PRNewswire/ -- Aetna International today announced it is waiving cost-sharing, co-pay and other deductibles for inpatient hospital admissions related to COVID-19, as part of several additional steps to help international medical insurance members access the care that t...
2020-04-08 16:52
2756
Week's Top Stories
Most Reposted
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 323 media titles]
2025-01-13 09:05
URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 293 media titles]
2025-01-13 10:44
Gen Z Travelers Drive Buy Now, Plan Later Travel Bookings by Over 20%: Fliggy's 2024 Buy Now Plan Later Travel Insight
[Picked up by 286 media titles]
2025-01-10 16:04RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 284 media titles]
2025-01-14 21:00
VANTAGE FOUNDATION SUPPORTS GRAB INDONESIA IN EMPOWERING WOMEN DRIVER-PARTNER
[Picked up by 280 media titles]
2025-01-09 18:26
Most Read
Hyundai Motor Group Partners with NVIDIA to Accelerate Development of AI Solutions for Future Mobility
2025-01-10 01:00
20322
AIMA Unveils Game-Changing 2025 eBike Lineup at CES: Better Performance, More Freedom
2025-01-09 02:34
6480
RingConn Takes Center Stage at CES 2025 with Innovative Wearables: Gen 2 and Gen 2 Air
2025-01-11 01:00
5610
Boqii Announces ADS Ratio Change
2025-01-11 05:30
4945
Sino Land Included in Dow Jones Sustainability World Index
2025-01-10 22:01
4926
